Fetal Exposure to Alcohol as Evidenced by Fatty Acid Ethyl Esters in Meconium in the Absence of Maternal Drinking History in Pregnancy
Authors:
- Julia KleinJKJulia Klein
- Tatyana KaraskovTKTatyana Karaskov
- Gideon KorenGKGideon Koren
- 1 October 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 26 (5) , 474-481
Abstract
The detection of fatty acid ethyl esters (FAEE) in neonatal meconium has been proposed as a novel screening method for intrauterine exposure to alcohol. We investigated the potential use of meconium FAEE screening in a high-risk neonatal population in the absence of maternal drinking history. One hundred forty-two meconium samples of neonates suspected of intrauterine illicit substance exposure and referred to the Motherisk Laboratory were analyzed for the existence of drugs by enzyme-linked immunosorbent assay (ELISA) and FAEE by gas chromatography-flame ionization detection (GC-FID). A positive FAEE test was previously defined as a cumulative measurement of 7 individual FAEE ≥2 nmol/g. Seventy-one percent of the samples tested positive for at least 1 illicit drug, with cannabis being the most prevalent (52.3%). Fourteen percent of all samples tested positive for prenatal alcohol exposure, as evidenced by cumulative meconium FAEE ≥2 nmol/g. Ethyl oleate, linoleate, palmitate, and arachidonate were detected most often and at the highest levels. At least 3 individual FAEE were detected in 95% of all positive samples, and none could be identified by the use of 1 selected FAEE. Significantly elevated levels of FAEE above the baseline and the presence of multiple FAEE species in meconium are exclusive to neonates who have likely been exposed to excessive amounts of alcohol in utero. Babies born to mothers who are suspected to use illicit drugs in pregnancy are at elevated risk for exposure also to alcohol in utero. Meconium FAEE are emerging biologic markers that can potentially facilitate earlier diagnosis and intervention for less apparent forms of alcohol-related disabilities that cannot be confirmed in the absence of maternal drinking history.Keywords
This publication has 12 references indexed in Scilit:
- Validation of a new biomarker of fetal exposure to alcoholThe Journal of Pediatrics, 2003
- Population Baseline of Meconium Fatty Acid Ethyl Esters Among Infants of Nondrinking Women in Jerusalem and TorontoTherapeutic Drug Monitoring, 2003
- Prevalence of Fatty Acid Ethyl Esters in Meconium SpecimensClinical Chemistry, 2003
- Identifying Maternal Self‐Reported Alcohol Use Associated With Fetal Alcohol Spectrum DisordersAlcohol, Clinical and Experimental Research, 2001
- Fatty Acid Ethyl Esters: A Novel Biologic Marker for Heavy In Utero Ethanol Exposure: A Case ReportTherapeutic Drug Monitoring, 1999
- Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorderTeratology, 1997
- Limited Ethanol Exposure Selectively Alters the Proliferation of Precursor Cells in the Cerebral CortexAlcohol, Clinical and Experimental Research, 1996
- Alcohol drinking in pregnancyGeneral Hospital Psychiatry, 1994
- Changes in Hyaluronan Deposition during Early Respiratory Distress Syndrome in Premature MonkeysPediatric Research, 1994
- RECOGNITION OF THE FETAL ALCOHOL SYNDROME IN EARLY INFANCYThe Lancet, 1973